When disaggregating by treatment required, 410 (20.0%) people required treatment for hypertension; 69 (3.3%) for diabetes; 74 (3.2%) for statin and/or aspirin; and 18 (0.6%) required an ACE-inhibitor (Table 4). The gene discussed is ACE; the disease is diabetes mellitus.